Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
暂无分享,去创建一个
I. Landrieu | J. Wieruszeski | G. Lippens | X. Hanoulle | C. Tokarski | C. Hackenberger | C. Rolando | Caroline Smet-Nocca | Malgorzata Broncel | Arnaud Leroy
[1] I. Landrieu,et al. Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E , 2010, The Journal of Biological Chemistry.
[2] L. Buée,et al. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. , 2010, Biochemical Society transactions.
[3] G. Davies,et al. Structural analyses of enzymes involved in the O-GlcNAc modification. , 2010, Biochimica et biophysica acta.
[4] J. Shabanowitz,et al. Enrichment and Site Mapping of O-Linked N-Acetylglucosamine by a Combination of Chemical/Enzymatic Tagging, Photochemical Cleavage, and Electron Transfer Dissociation Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.
[5] Jianhua Shi,et al. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. , 2009, Brain : a journal of neurology.
[6] I. Landrieu,et al. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] S. Shenolikar,et al. From promiscuity to precision: protein phosphatases get a makeover. , 2009, Molecular cell.
[8] D. Schwarzer,et al. Chemoselective ligation and modification strategies for peptides and proteins. , 2008, Angewandte Chemie.
[9] G. Hart,et al. O-Linked β-N-Acetylglucosaminyltransferase Substrate Specificity Is Regulated by Myosin Phosphatase Targeting and Other Interacting Proteins* , 2008, Journal of Biological Chemistry.
[10] Yigong Shi,et al. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. , 2008, Molecular cell.
[11] A. W. Schüttelkopf,et al. Structural insights into mechanism and specificity of O-GlcNAc transferase , 2008, The EMBO journal.
[12] P. Fischer. Turning down tau phosphorylation. , 2008, Nature chemical biology.
[13] G. Davies,et al. Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation , 2008, Nature Structural &Molecular Biology.
[14] G. Davies,et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. , 2008, Nature chemical biology.
[15] I. Landrieu,et al. Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry. , 2008, Biochemical and biophysical research communications.
[16] V. Janssens,et al. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). , 2008, Trends in biochemical sciences.
[17] Linda C Hsieh-Wilson,et al. Chemical approaches to understanding O-GlcNAc glycosylation in the brain. , 2008, Nature chemical biology.
[18] I. Grundke‐Iqbal,et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease , 2008, FEBS letters.
[19] Scott B Ficarro,et al. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. , 2007, Nature chemical biology.
[20] Gerald W. Hart,et al. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.
[21] Barry M Wise,et al. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. , 2006, Biochemistry.
[22] H. Paudel,et al. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. , 2006, Biochemistry.
[23] K. Saxena,et al. NMR Analysis of a Tau Phosphorylation Pattern , 2006 .
[24] H. Paudel,et al. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. , 2006, Biochemistry.
[25] S. Walker,et al. Discovery of O-GlcNAc transferase inhibitors. , 2005, Journal of the American Chemical Society.
[26] L. Buée,et al. Regulation of Pin1 peptidyl‐prolyl cis/trans isomerase activity by its WW binding module on a multi‐phosphorylated peptide of Tau protein , 2005, FEBS letters.
[27] K. Kosik,et al. Phosphorylated tau and the neurodegenerative foldopathies. , 2005, Biochimica et biophysica acta.
[28] G. Johnson,et al. Tau phosphorylation: physiological and pathological consequences. , 2005, Biochimica et biophysica acta.
[29] A. Delacourte,et al. Tau protein as a differential biomarker of tauopathies. , 2005, Biochimica et biophysica acta.
[30] I. Landrieu,et al. Accepting its Random Coil Nature Allows a Partial NMR Assignment of the Neuronal Tau Protein , 2004, Chembiochem : a European journal of chemical biology.
[31] M. Jinek,et al. The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α , 2004, Nature Structural &Molecular Biology.
[32] G. Hart,et al. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Kirschner,et al. The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.
[34] A. Delacourte,et al. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. , 2003, Biochimica et biophysica acta.
[35] J. Hanover,et al. Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. , 2003, Archives of biochemistry and biophysics.
[36] N. Leymarie,et al. Tandem mass spectrometry for structural characterization of proline-rich proteins: application to salivary PRP-3. , 2002, Analytical chemistry.
[37] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.
[38] V. Janssens,et al. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.
[39] René Hen,et al. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .
[40] M. Mercken,et al. Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice* , 2000, The Journal of Biological Chemistry.
[41] D. Craik,et al. Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. , 2000, Biochemistry.
[42] L. Johnson,et al. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.
[43] U. Wagner,et al. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase‐3β transgenes , 1997, Neuroreport.
[44] G. Hart,et al. The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine* , 1996, The Journal of Biological Chemistry.
[45] R. Crowther,et al. Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles , 1996, Acta Neuropathologica.
[46] M. Goedert,et al. Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .
[47] K. Titani,et al. Hyperphosphorylation of Tau in PHF , 1995, Neurobiology of Aging.
[48] E. Vanmechelen,et al. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.
[49] K. Titani,et al. Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.
[50] Simon Lovestone,et al. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.
[51] I. Grundke‐Iqbal,et al. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A , 1994, Neuroscience.
[52] P. Cohen,et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.
[53] E. Mandelkow,et al. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcmeurin and phosphatase‐2A , 1993, FEBS letters.
[54] J. Woodgett,et al. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.